Role of the non‐hypervariable FR3 D‐E loop in single‐domain antibody recognition of haptens and carbohydrates

Abstract

Single-domain antibodies (sdAbs), the variable domains of camelid heavy chain-only antibodies, are generally thought to poorly recognize nonproteinaceous small molecules and carbohydrates in comparison with conventional antibodies. However, the structures of anti-methotrexate, anti-triclocarban and anti-cortisol sdAbs revealed unexpected contributions of the non-hypervariable "CDR4" loop, formed between β-strands D and E of framework region 3, in binding. Here, we investigated the potential role of CDR4 in sdAb binding to a hapten, 15-acetyl-deoxynivalenol (15-AcDON), and to carbohydrates. We constructed and panned a phage-displayed library in which CDR4 of the 15-AcDON-specific sdAb, NAT-267, was extended and randomized. From this library, we identified one sdAb, MA-232, bearing a 14-residue insertion in CDR4 and showing improved binding to 15-AcDON by ELISA and surface plasmon resonance.On the basis of these results, we constructed a second set of phage-displayed libraries in which the CDR4 and other regions of three hapten-or carbohydrate-binding sdAbs were diversified. With the goal of identifying sdAbs with novel glycan-binding specificities, we panned the library against four tumor-associated carbohydrate antigens but were unable to enrich binding phages. Thus, we conclude that while CDR4 may play a role in binding of some rare hapten-specific sdAbs, diversifying this region through molecular engineering is probably not a general solution to sdAb carbohydrate recognition in the absence of a paired V L domain. KEYWORDS 15-acetyl-deoxynivalenol, carbohydrate, CDR4, hapten, heavy chain-only antibody, phage display, single-domain antibody, V H H

Conformational changes in a Vernier zone region: Implications for antibody dual specificity

“…However, the HV4 region on a heavy chain could be another candidate for such specificity modulation. Some studies called HV4 and LV4 loops “CDR4s” due to their potential effects on antigen binding, 55 our study supports this claim by showing the potential of LV4 for antigen affinity/specificity modulation. Although Vernier zone residues were previously reported to be important for humanization efforts and binding affinity, 33,62 they are mostly underrepresented in the literature 28 .…”

“…These loops reside on Framework‐3 and they are non‐hypervariable 53,54 . Some studies called this loop “CDR4” due to its potential effect on antigen binding 55 . In this study, we show that one of Vernier zone regions, LV4, makes an extraordinary close contact with LCDR1 in dual‐specific antibodies.…”

Chemiluminescent Enzyme Immunoassay and Bioluminescent Enzyme Immunoassay for Tenuazonic Acid Mycotoxin by Exploitation of Nanobody and Nanobody–Nanoluciferase Fusion

“…In addition, the sensitivity of ic-ELISA based on Nb-3F9 showed the highest sensitivity (Figure 2B), which demonstrated that the sequences in FR could also affect antigen−antibody binding activity although these sequences were universally conserved. 28,29 On the basis of the results above, nanobodies against TeA high sensitivity were isolated by phage display technology along with the stringent biopanning. Moreover, the best anti-TeA clone Nb-3F9 was cloned into the modified pET22b vector containing Nluc gene to generate biofunctional nanobody fusion.…”

Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens

“…Currently, no Nb-based CAR T-cell targeting a TACA has been described. Moreover, obtaining purely anti-glycan Nbs is still challenging 40 . Interestingly, we recently reported the development of a specific Nb against Globo-H, a glycosphingolipid expressed in many solid tumours.…”